Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration

Liver International

Volumn 25, Issue 3, 2005, Pages 595-603

  Okada, Chizuko ^a   Akbar, Fazle ^a   Horiike, Norio ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AMA; Animal model; Poly I:C; Primary biliary cirrhosis; Type 1 interferon

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; INTERFERON INDUCING AGENT; MITOCHONDRION ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELL INFILTRATION; CHOLANGITIS; CHOLESTASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GENETIC SUSCEPTIBILITY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; INTERFERON INDUCTION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS;

ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; FEMALE; INTERFERON INDUCERS; INTERFERON TYPE I; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LIVER; LIVER CIRRHOSIS, BILIARY; MICE; MICE, INBRED C57BL; POLY I-C;

EID: 20844439570     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01043.x     Document Type: Article

References (36)

1. Gershwin M E, Nishio A, Ishibashi H, Lindor K D. Primary biliary cirrhosis. In: Gershwin M E, Vierling J M, Manns M P, eds. Liver Immunology. Philadelphia: Harley & Belfus Inc., 2002; 311-27.
2. Walker J G, Doniach D, Roitt I M, Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965; 1: 827-31.
3. Coppel R L, McNeilage L J, Surh C D, Van de Water J, Spithill T W, Whittingham S, Gershwin M E. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 1988; 85: 7317-21.
4. Gershwin M E, Mackay I R, Sturgess A, Coppel R L. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138: 3525-31.
5. Yeaman S J, Fussey S P, Danner D J, James O F, Mutimer D J, Bassendine M F. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1988; 1: 1067-70.
6. Surh C D, Roche T E, Danner D J, Ansari A, Coppel R L, Prindiville T, Dickson E R, Gershwin M E. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex. Hepatology 1989; 10: 127-33.
7. Long R G, Scheuer P J, Sherlock S. Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology 1977; 72: 1204-7.
8. Mahl T C, Shockcor W, Boyer J L. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994; 20: 707-13.
9. Springer J, Cauch-Dudek K, O'Rourke K, Wanless I R, Heathcote E J. Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol 1999; 94: 47-53.
10. Vierling J M. Animal models of autoimmune diseases of the liver. In: Gershwin M E, Vierling J M, Manns M P, eds. Liver Immunology. Philadelphia: Harley & Belfus Inc., 2002; 263-90.
11. Hayashi Y, Utsuyama M, Kurashima C, Hirokawa K. Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice. Clin Exp Immunol 1989; 78: 120-6.
12. Kanda K, Onji M, Ohta Y. Spontaneous occurrence of autoimmune cholangitis in senescent mice. J Gastroenterol Hepatol 1993; 8: 7-14.
13. Ytterberg S R, Schnitzer T J. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982; 25: 401-6.
14. Preble O T, Black R J, Friedman R M, Klippel J H, Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982; 216: 429-31.
15. Cesario T C, Andrews B S, Martin D A, Jason M, Treadwell T, Friou G, Tilles J G. Interferon in synovial fluid and serum of patients with rheumatic disease. J Rheumatol 1983; 10: 647-50.
16. Taniguchi Y, Murakami T, Nakanishi K, Tamai M, Matsuura B, Masumoto T, Onji M, Tajiri J, Noguchi S, Ohta Y. Two cases of hypothyroidism associated with alpha-interferon therapy. Intern Med 1992; 31: 373-6.
17. Abdi E A, Venner P M. Immune thrombocytopenia after alpha-interferon therapy in patients with cancer. JAMA 1986; 255: 1878-9.
18. Yoshikawa M, Mimura M, Shiroi A, Kojima H, Fukui H, Sugimoto Y, Mochi T. Primary biliary cirrhosis exacerbated by a course of acute hepatitis C and subsequent interferon therapy. Am J Gastroenterol 2000; 95: 2396-7.
19. D'Amico E, Paroli M, Fratelli V, Palazzi C, Barnaba V, Callea F, Consoli G. Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection. Dig Dis Sci 1995; 40: 2113-6.
20. Maeda T, Onishi S, Miura T, Iwamura S, Tomita A, Saibara T, Yamamoto Y. Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C. Dig Dis Sci 1995; 40: 1226-30.
21. Field A K, Tytell A A, Lampson G P, Hilleman M R. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci USA 1967; 58: 1004-10.
22. Qu W M, Miyazaki T, Terada M, Okada K, Mori S, Kanno H, Nose M. A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic: polycytidylic acid. Clin Exp Immunol 2002; 129: 27-34.
23. Sasaki M, Allina J, Odin J A, Thung S N, Coppel R, Nakanuma Y, Gershwin M E. Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol 2002; 9: 103-11.
24. Jones D E, Palmer J M, Kirby J A, De Cruz D J, McCaughan G W, Sedgwick J D, Yeaman S J, Burt A D, Bassendine M F. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver 2000; 20: 351-6.
25. Surh C D, Roche T E, Danner D J, Ansari A, Coppel R L, Prindiville T, Dickson E R, Gershwin M E. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex. Hepatology 1989; 10: 127-33.
26. Jong-Hon K, Yajima R, Karino Y, Yoshida J, Tsuji K, Watanabe S, Horada K, Itoh Y, Sekiguchi K, Toyoda S, Maekubo H. Development of a new enzyme-linked immunosorbent assay for the detection of anti-M2 in primary biliary cirrhosis. Hepatol Res 2001; 21: 1-7.
27. Steinberg A D, Baron S, Talal N. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci USA 1969; 63: 1102-7.
28. Sobel D O, Ewel C H, Zeligs B, Abbassi V, Rossio J, Bellanti J A. Poly I: C induction of alpha-interferon in the diabetes-prone BB and normal Wistar rats. Dose-response relationships. Diabetes 1994; 43: 518-22.
29. Braun D, Geraldes P, Demengeot J. Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J Autoimmun 2003; 20: 15-25.
30. Stewart TA. Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases. Cytokine Growth Factor Rev 2003; 14: 139-54.
31. Hanada S, Harada M, Koga H, Kawaguchi T, Taniguchi E, Kumashiro R, Ueno T, Ueno Y, Ishii M, Sakisaka S, Sata M. Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver Int 2003; 23: 3-11.
32. Torres B A, Johnson H M. Lipopolysaccharide and polyribonucleotide activation of macrophages: implications for a natural triggering signal in tumor cell killing. Biochem Biophys Res Commun 1985; 131: 395-401.
33. Kadowaki N, Antonenko S, Liu Y J. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c-type 2 dendritic cell precursors and CD11c+dendritic cells to produce type I IFN. J Immunol 2001; 166: 2291-5.
34. Ralph P, Nakoinz I, Rennick D. Role of interleukin 2, interleukin 4, and alpha, beta, and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity. J Exp Med 1988; 167: 712-7.
35. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-55.
36. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough D F. Type 1 interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461-70.